CLINICAL TRIALS PROFILE FOR FLURPIRIDAZ F-18
✉ Email this page to a colleague
All Clinical Trials for FLURPIRIDAZ F-18
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01347710 ↗ | A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. | Completed | Lantheus Medical Imaging | Phase 3 | 2011-06-01 | The primary objective of the study is to assess the diagnostic efficacy (specificity and sensitivity) of flurpiridaz F18 injection PET myocardial perfusion imaging (MPI) compared to single photon emission computed tomography (SPECT) MPI in the detection of significant coronary artery disease (CAD) as defined by invasive coronary angiography (ICA) or a documented history of Myocardial Infarction (MI). |
NCT01681524 ↗ | Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI | Withdrawn | Lantheus Medical Imaging | Phase 3 | 2012-11-01 | The study will evaluate the use of Flurpiridaz F18 injection in patients with CAD to determine if the study drug in PET imaging is better than SPECT imaging currently used for this purpose. |
NCT03354273 ↗ | An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD) | Recruiting | Pharmaceutical Product Development, LLC | Phase 3 | 2018-06-08 | This is a Phase 3, prospective, open-label, international, multicentre study of Flurpiridaz (18F) Injection for PET MPI in patients referred for ICA because of suspected CAD. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for FLURPIRIDAZ F-18
Condition Name
Clinical Trial Locations for FLURPIRIDAZ F-18
Trials by Country
Clinical Trial Progress for FLURPIRIDAZ F-18
Clinical Trial Phase
Clinical Trial Sponsors for FLURPIRIDAZ F-18
Sponsor Name